Daiken Biomedical Co., Ltd. (TPE:7780)

Taiwan · Delayed Price · Currency is TWD

16.95

-0.10 (-0.59%)

At close: Aug 28, 2026

-49.85% (1Y)

Market Cap	13.65B -32.7%
Revenue (ttm)	2.19B +34.3%
Net Income	424.96M +72.1%
EPS	0.55 +34.5%
Shares Out	805.56M
PE Ratio	30.78
Forward PE	n/a
Dividend	0.70 (4.15%)
Ex-Dividend Date	Sep 3, 2026

Volume	412,740
Open	17.05
Previous Close	17.05
Day's Range	16.90 - 17.10
52-Week Range	16.00 - 34.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Daiken Biomedical

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company was founded in 2018 and is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. operates as a subsidiary of Sunfun Info Co., Ltd. [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 2018

Country Taiwan

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 7780

Full Company Profile

Financial Performance

In 2025, Daiken Biomedical's revenue was 1.90 billion, an increase of 39.10% compared to the previous year's 1.36 billion. Earnings were 337.87 million, an increase of 217.01%.

Financial Statements